secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVENUE THERAPEUTICS, INC. (ATXI)
CIK:        0001644963
Form:       8-K
Filed at:   2023-06-26T23:59:59+00:00
Accession:  0001104659-23-074745
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Avenue Therapeutics stockholders elect six directors, ratify KPMG, approve say-on-pay at 3-year frequency
--------------------------------------------------------------------------------

- All six director nominees elected with >9.5M votes each; broker non-votes ~1.37M.
- Ratification of KPMG as auditor for FY2023 passed with 10.8M for, 246K against.
- Advisory vote on executive compensation approved with 9.5M for, 128K against.
- Say-on-pay frequency set at every 3 years on advisory basis (9.4M votes for 3 years).
- Meeting held virtually June 22, 2023; quorum achieved with majority voting power.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644963/000110465923074745/0001104659-23-074745-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644963/000110465923074745/tm2319602d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-074745

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer